CHEK1 and breast carcinoma: Here, using breast cancer as a model, we undertake a systematic evaluation of the relative contribution of dysregulation of each cell cycle checkpoint kinase to the formation of tumors of distinct subtypes, metastatic progression, and treatment responsiveness with a range of informatic and experimental approaches as described below.